Health Care Blog December 12, 2024
Saurabh Jha

Early on in the COVID-19 pandemic a seroprevalence study from Santa Clara indicated that the viral spread was far greater than was believed. The study suggested that the infection fatality rate (IFR) was much lower than the case fatality rate and perhaps even lower than the suspected IFR. The researchers estimated that 2.8% of the county had been infected by April 2020. The virus was contagious and, most importantly, caused many asymptomatic infections.

The study, released as a preprint within a month of the lockdown, should have been published by the NEJM or Lancet. The specificity of the immunoassay was a whopping 99.5% and could not have been lower than 98.5%. Instead, it was roundly criticized by born-again methodological...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies
How Donald Trump Is Reshaping Global Health
AAFP’s prescription for primary care success in 2025
Executive Orders Suggest Swift Pivot in Managed Care and Health Policy
InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders
Medicare Negotiations Could Fuel, Not Stifle, Innovation

Share This Article